Who Would Be a Research Candidate for Each Compound In clinical terms, tirzepatide is currently the only one of the two compounds available for prescription use, making it the accessible option for patients with type 2 diabetes or obesity meeting specific criteria
Information for healthcare professionals The GLP-1 receptor agonists Bydureon, Byetta, Lyxumia, Ozempic, Rybelsus, Trulicity and Victoza are indicated for diabetes only, Saxenda and Wegovy are indicated for weight management as an adjunct to diet and exercise in people who have obesity or overweight with weight-related health issues
As it is essential, and the potential for impaired synthesis or increased needs are not clear, it remains mandatory in infant formula
Semaglutide naturally reduces appetite and slows stomach emptying, so large meals overwhelm your digestive capacity and increase diarrhea risk